|
2026 Journal Article Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testingStewart, Adam G., Douglas, Abby P., Kidd, Sarah E., Salmanton-García, Jon, Cornely, Oliver A., Morris, Arthur J., Halliday, Catriona L. and Chen, Sharon C-A. (2026). Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testing. Pathology, 58 (3), 341-346. doi: 10.1016/j.pathol.2025.09.012 |
|
2026 Journal Article Current Epidemiology and Infection Characteristics of Non- <i>Aspergillus</i> Mold Infections: A Multicenter Study in Australia and New ZealandNeoh, Chin Fen, Chen, Sharon C-A, Morris, Arthur J, Heath, Christopher H, Tan, Shu Jin, Lane, Rebekah, Tio, Shio Yen, Tay, Sze Yen, Roberts, Matthew B, Kennedy, Karina, van Hal, Sebastiaan J, Murray, Hugh C, Pickles, Robert, Vaselli, Natasha Marcella, Douglas, Abby, Urbancic, Karen, Menon, Mahesh, Stewart, Adam, Howard, Julia C, Keighley, Caitlin, Miyakis, Spiros, Beresford, Rohan, Cooley, Louise, Sehu, Marjoree, Halliday, Catriona L, Kidd, Sarah, Kong, David C M, Spelman, Tim, Worth, Leon J ... Yee Yong, Kar (2026). Current Epidemiology and Infection Characteristics of Non- Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand. Clinical Infectious Diseases ciag029. doi: 10.1093/cid/ciag029 |
|
2026 Journal Article The impact of geography and antimicrobial resistance on the incidence and outcomes of Elizabethkingia species bloodstream infectionStewart, Adam G., Edwards, Felicity and Laupland, Kevin B. (2026). The impact of geography and antimicrobial resistance on the incidence and outcomes of Elizabethkingia species bloodstream infection. Diagnostic Microbiology and Infectious Disease, 114 (1) 117106, 1-4. doi: 10.1016/j.diagmicrobio.2025.117106 |
|
2025 Journal Article Differences in clinical outcomes among patients with mold fungemiaStewart, Adam G., Laupland, Kevin B., Edwards, Felicity, Chen, Sharon C-A. and Slavin, Monica A. (2025). Differences in clinical outcomes among patients with mold fungemia. Open Forum Infectious Diseases, 13 (1) ofaf793, ofaf793. doi: 10.1093/ofid/ofaf793 |
|
2025 Journal Article Convalescent plasma in hospitalised patients with COVID-19Mcquilten, Zoe, O'sullivan, Matthew V. N., Purcell, Damien, Edler, Peta, Meagher, Niamh, Alcorn, Kylie, Bowen, Asha, Daly, James, Foo, Hong, Goulding, Susan, Gosbell, Iain, Hammond, Naomi, Hills, Thomas, Hoad, Veronica, Jha, Vivekanand, Lim, Lyn Li, Mcphee, Grace, Molton, James, Morpeth, Susan, Nguyen, Vi, Paterson, David, Rees, Megan, Roberts, Jason, Rogers, Benjamin A., Stewart, Adam, Sasadeusz, Joe, Snelling, Thomas, Venkatesh, Balasubramanian, Wood, Erica ... Denholm, Justin T. (2025). Convalescent plasma in hospitalised patients with COVID-19. Internal Medicine Journal, 55 (12), 2024-2032. doi: 10.1111/imj.70253 |
|
2025 Journal Article Bloodstream infection and risk for plasma cell neoplasms: a population‐based cohort studyStewart, Adam G., Edwards, Felicity and Laupland, Kevin B. (2025). Bloodstream infection and risk for plasma cell neoplasms: a population‐based cohort study. Transplant Infectious Disease, 27 (6) e70110, e70110. doi: 10.1111/tid.70110 |
|
2025 Journal Article Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trialPaterson, David L., Sulaiman, Helmi, Liu, Po-Yu, Chatfield, Mark D., Yilmaz, Mesut, Salmuna, Zeti Norfidiyati, Mazlan, Mohd Zulfakar, Anunnatsiri, Siriluck, Sirijatuphat, Rujipas, Chotiprasitsakul, Darunee, Lye, David C., Somani, Jyoti, Kalimuddin, Shirin, Aslan, Abdullah T., Thamlikitkul, Visanu, Lee, Yi-Tzu, Yang, Ya-Sung, Lin, Yi-Tsung, Ramli, Wan Nurliyana Wan, Tseng, Chien-Hao, Archuleta, Sophia, Chan, Yvonne Fu Zi, Forde, Brian M., Wright, Hugh, Stewart, Adam G., Ramsay, Kay A., Ling, Weiping, Rossi, Vicki, Harris-Brown, Tiffany M. and Harris, Patrick N. A. (2025). Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trial. The Lancet Infectious Diseases, 26 (2), 148-159. doi: 10.1016/s1473-3099(25)00469-4 |
|
2025 Other Outputs Treatment strategies for extended-spectrum beta-lactamase (ESBL) and AmpC-producing EnterobacteralesStewart, Adam (2025). Treatment strategies for extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales. PhD Thesis, Faculty of Medicine, The University of Queensland. doi: 10.14264/28ac0b5 |
|
2025 Journal Article Epidemiology, Significance and Clinical Outcomes of Bloodstream Infections Caused by Non‐Candida and Non‐Cryptococcus YeastsStewart, Adam G., Laupland, Kevin B., Edwards, Felicity, Slavin, Monica A. and Chen, Sharon C.‐A. (2025). Epidemiology, Significance and Clinical Outcomes of Bloodstream Infections Caused by Non‐Candida and Non‐Cryptococcus Yeasts. Mycoses, 68 (7) e70093, 1-9. doi: 10.1111/myc.70093 |
|
2025 Journal Article Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistanceStewart, Adam G., Laupland, Kevin B., Edwards, Felicity, Koo, Sophia, Hammond, Sarah P., Harris, Patrick N. A., Paterson, David L., Slavin, Monica A. and Chen, Sharon C-A (2025). Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance. Journal of Infection, 91 (1) 106513, 1-11. doi: 10.1016/j.jinf.2025.106513 |
|
2025 Journal Article Clinical characteristics and outcomes in patients with Cryptococcaemia from a large population-based cohortStewart, Adam G., Laupland, Kevin B., Edwards, Felicity, Gassiep, Ian, Koo, Sophia, Hammond, Sarah P., Chen, Sharon C.-A. and Slavin, Monica A. (2025). Clinical characteristics and outcomes in patients with Cryptococcaemia from a large population-based cohort. Mycoses, 68 (7) e70091, 1-10. doi: 10.1111/myc.70091 |
|
2025 Journal Article Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trialStewart, Adam G., Harris, Patrick N. A., Graham, Rikki M. A., Jennison, Amy V., Schlebusch, Sanmarie, Kakkanat, Asha, Harris-Brown, Tiffany, Paterson, David L. and Forde, Brian M. (2025). Differences in antimicrobial resistance gene abundance and microbial diversity of the gut microbiome in patients on antibiotics enrolled in a clinical trial. Therapeutic Advances in Infectious Disease, 12 20499361251337597, 1-12. doi: 10.1177/20499361251337597 |
|
2025 Journal Article Unravelling T cell immunity in CAR-T therapy: implications for influenza vaccinationStewart, Adam G. and Chemaly, Roy F. (2025). Unravelling T cell immunity in CAR-T therapy: implications for influenza vaccination. Transplantation and Cellular Therapy, 31 (5), 282-284. doi: 10.1016/j.jtct.2025.04.003 |
|
2025 Journal Article Population pharmacokinetic modelling of remdesivir and its metabolite GS-441524 in hospitalised patients with COVID-19Roberts, Darren M., Liu, Xin, Parker, Suzanne L., Burke, Andrew, Peek, Jenny, Carland, Jane E., Murnion, Bridin, Seah, Vincent, Wallis, Steven C., Sumi, Chandra D., Pandey, Saurabh, Buscher, Hergen, Byrne, Anthony, Sandaradura, Indy, Bowen, David, Holz, Simon, Stewart, Adam G., Hajkowicz, Krispin M. and Roberts, Jason A. (2025). Population pharmacokinetic modelling of remdesivir and its metabolite GS-441524 in hospitalised patients with COVID-19. Clinical Pharmacokinetics, 64 (5) e0022222, 743-756. doi: 10.1007/s40262-025-01496-2 |
|
2025 Journal Article Community-onset bloodstream infection among people with opioid use disorders: a twenty-year population-based cohort study in Queensland, AustraliaLaupland, Kevin B., Stewart, Adam G., Edwards, Felicity, Harris, Patrick N. A. and Coulter, Sonali (2025). Community-onset bloodstream infection among people with opioid use disorders: a twenty-year population-based cohort study in Queensland, Australia. Infectious Diseases, 57 (7), 669-675. doi: 10.1080/23744235.2025.2471823 |
|
2025 Journal Article Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantationStewart, Adam G. and Chambers, Daniel C. (2025). Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation. The Journal of Heart and Lung Transplantation, 44 (3), 435-436. doi: 10.1016/j.healun.2024.11.043 |
|
2025 Journal Article Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomesStewart, Adam G., Harris, Patrick N. A., Edwards, Felicity, Kiani, Behzad, Paterson, David L. and Laupland, Kevin B. (2025). Klebsiella pneumoniae species complex bloodstream infection in adult patients: changing epidemiology and determinants of poor outcomes. Infection, 53 (3), 1179-1187. doi: 10.1007/s15010-024-02457-w |
|
2025 Journal Article Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluationBassetti, Matteo, Stewart, Adam, Bartalucci, Claudia, Vena, Antonio, Giacobbe, Daniele Roberto and Roberts, Jason (2025). Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluation. Expert Opinion On Drug Metabolism and Toxicology, 21 (2), 125-132. doi: 10.1080/17425255.2024.2424899 |
|
2024 Journal Article <i>Yersinia enterocolitica</i> Pneumonia in a Heart Transplant RecipientPortales Castillo, Carlos Alejandro, Stewart, Adam G. and Kotton, Camille N. (2024). Yersinia enterocolitica Pneumonia in a Heart Transplant Recipient. Transplant Infectious Disease, 27 (1) e14422, e14422. doi: 10.1111/tid.14422 |
|
2024 Journal Article Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohortStewart, Adam G., Edwards, Felicity, Harris, Patrick N. A., Paterson, David L. and Laupland, Kevin B. (2024). Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohort. European Journal of Clinical Microbiology and Infectious Diseases, 44 (2), 427-436. doi: 10.1007/s10096-024-05012-5 |
